0001193125-20-275712.txt : 20201125 0001193125-20-275712.hdr.sgml : 20201125 20201023200358 ACCESSION NUMBER: 0001193125-20-275712 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 CORRESP 1 filename1.htm Acceleration Request

October 23, 2020

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549-3720

 

Attention:   Courtney Lindsay
  Joe McCann
  David Burton
  Jeanne Baker
Re:   Biodesix, Inc.
  Registration Statement on Form S-1
  File No. 333-249260
  Acceleration Request
          Requested Date:     October 27, 2020
          Requested Time:    4:00 P.M., Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biodesix, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1, Registration Number 333-249260 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 P.M., Eastern Time, on October 27, 2020, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.

We would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Samir A. Gandhi of Sidley Austin LLP at (212) 839-5684.

 

Very truly yours,
/s/ Scott Hutton
Scott Hutton
President and Chief Executive Officer
Biodesix, Inc.

 

cc:

Robin Harper Cowie, Biodesix, Inc.

  

David Poticha, Biodesix, Inc.

  

Frank F. Rahmani, Sidley Austin LLP

  

Samir A. Gandhi, Sidley Austin LLP

  

Richard D. Truesdell, Jr., Davis Polk & Wardwell LLP

  

Yasin Keshvargar, Davis Polk & Wardwell LLP